Pharmaceutical Investing Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006
Pharmaceutical Investing Idera Pharmaceuticals Enters into a Clinical Development Support Agreement with Pillar Partners Foundation to Expand the Clinical Research on IMO-2125
Pharmaceutical Investing Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Pharmaceutical Investing Cellectar Granted Seminal U.S. Patent for Phospholipid-Ether Analogs as Cancer-Targeting Drug Vehicles
Pharmaceutical Investing Epizyme Reports Fourth Quarter and Full Year 2017 Operating Results and 2018 Milestones
Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors
Pharmaceutical Investing Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine
Precious Metals & Critical Minerals Hybrid Investor Conference: Presentations Now Available for Online Viewing
